RBC Europe’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$12K Hold
592
﹤0.01% 482
2022
Q1
$10K Hold
592
﹤0.01% 533
2021
Q4
$12K Hold
592
﹤0.01% 514
2021
Q3
$10.7K Hold
592
﹤0.01% 922
2021
Q2
$16K Hold
592
﹤0.01% 868
2021
Q1
$17.7K Hold
592
﹤0.01% 799
2020
Q4
$17K Hold
592
﹤0.01% 761
2020
Q3
$14.4K Hold
592
﹤0.01% 719
2020
Q2
$10.6K Hold
592
﹤0.01% 755
2020
Q1
$4.82K Buy
+592
New +$6.76K ﹤0.01% 833

Other funds holding CVET

RBC Europe's CVET Position: Q2 2022 in Review

RBC Europe held its Covetrus, Inc. Common Stock (CVET) position steady in Q2 2022 at 592 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #482.

RBC Europe first reported a position in CVET in Q1 2020 and has held it in 10 quarters since. The position peaked at $17.7K in Q1 2021. 266 funds tracked by Wall St. Rank hold CVET as of Q2 2022.

  • RBC Europe held 592 shares of Covetrus, Inc. Common Stock worth $12K as of Q2 2022.
  • RBC Europe left its Covetrus, Inc. Common Stock share count unchanged in Q2 2022.
  • Covetrus, Inc. Common Stock made up ﹤0.01% of RBC Europe's portfolio in Q2 2022, its #482 holding.
  • RBC Europe first reported a position in Covetrus, Inc. Common Stock in Q1 2020 and has held it in 10 quarters since.
  • RBC Europe's Covetrus, Inc. Common Stock position peaked at $17.7K in Q1 2021.
  • 266 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q2 2022.

Based on RBC Europe's 13F filing for Q2 2022, filed 14 Nov 2022.